First Time Loading...
S

Shin Nippon Biomedical Laboratories Ltd
TSE:2395

Watchlist Manager
Shin Nippon Biomedical Laboratories Ltd
TSE:2395
Watchlist
Price: 1 385 JPY 0.22% Market Closed
Updated: Jun 10, 2024

Shin Nippon Biomedical Laboratories Ltd
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Shin Nippon Biomedical Laboratories Ltd
Capital Expenditures Peer Comparison

Comparables:
2309
2370
4880
2183
7079

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
S
Shin Nippon Biomedical Laboratories Ltd
TSE:2395
Capital Expenditures
-¥8.6B
CAGR 3-Years
-97%
CAGR 5-Years
-51%
CAGR 10-Years
-17%
CMIC Holdings Co Ltd
TSE:2309
Capital Expenditures
-¥6.2B
CAGR 3-Years
10%
CAGR 5-Years
-1%
CAGR 10-Years
-6%
Medinet Co Ltd
TSE:2370
Capital Expenditures
-¥77.1m
CAGR 3-Years
-28%
CAGR 5-Years
12%
CAGR 10-Years
5%
CellSource Co Ltd
TSE:4880
Capital Expenditures
-¥359m
CAGR 3-Years
-122%
CAGR 5-Years
-71%
CAGR 10-Years
N/A
Linical Co Ltd
TSE:2183
Capital Expenditures
-¥6.5m
CAGR 3-Years
54%
CAGR 5-Years
37%
CAGR 10-Years
5%
WDB coco Co Ltd
TSE:7079
Capital Expenditures
-¥87.2m
CAGR 3-Years
-250%
CAGR 5-Years
-171%
CAGR 10-Years
N/A

See Also

What is Shin Nippon Biomedical Laboratories Ltd's Capital Expenditures?
Capital Expenditures
-8.6B JPY

Based on the financial report for Mar 31, 2024, Shin Nippon Biomedical Laboratories Ltd's Capital Expenditures amounts to -8.6B JPY.

What is Shin Nippon Biomedical Laboratories Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-17%

Over the last year, the Capital Expenditures growth was -74%. The average annual Capital Expenditures growth rates for Shin Nippon Biomedical Laboratories Ltd have been -97% over the past three years , -51% over the past five years , and -17% over the past ten years .